Our Pricing

Searching for cheap weight loss injections UK options that don't compromise on quality? At Cured Pharmacy, we offer transparent upfront pricing on all licensed GLP-1 treatments including Mounjaro, Wegovy, and Saxenda, with every prescription dispensed following a free clinical assessment by our UK-registered prescribers. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every patient receives genuine UK-licensed medications at the lowest guaranteed prices in the UK.

How GLP-1 Weight Loss Injections Work

GLP-1 receptor agonists represent the most clinically effective weight loss medications currently licensed by the MHRA in the UK. These injections mimic naturally occurring hormones that regulate appetite, slow gastric emptying, and improve insulin sensitivity—creating a multi-pathway approach to sustainable weight reduction [1].

Clinical trials demonstrate that patients using GLP-1 treatments achieve significantly greater weight loss compared to lifestyle modification alone. The STEP trials showed that semaglutide (Wegovy) produced an average 14.9% body weight reduction over 68 weeks, whilst the SURPASS-3 trial demonstrated that tirzepatide (Mounjaro) achieved up to 22.5% average weight reduction over 72 weeks [1][2].

These medications work by binding to GLP-1 receptors in the brain, pancreas, and digestive system. Tirzepatide offers dual action by also activating GIP receptors, which may explain its superior efficacy in head-to-head comparisons. All injectable GLP-1 treatments require subcutaneous administration, typically into the abdomen, thigh, or upper arm [2].

Comparing Cheap Weight Loss Injections UK: Mounjaro vs Wegovy vs Saxenda

Whilst all three treatments belong to the GLP-1 class, they differ significantly in mechanism, dosing frequency, and clinical outcomes. Mounjaro (tirzepatide) is the UK's first dual GIP/GLP-1 receptor agonist, offering the highest average weight loss in clinical trials but at a higher price point. Wegovy (semaglutide) provides once-weekly injections with robust clinical evidence and competitive UK pricing. Saxenda (liraglutide) requires daily injections but offers the most affordable entry point for patients new to injectable weight loss treatments [3].

Your suitability for each medication depends on multiple factors including your BMI, medical history, previous weight loss attempts, and tolerance for injection frequency. Patients with a history of pancreatitis, medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2 may not be suitable candidates for GLP-1 treatments [4].

At Cured Pharmacy, our UK prescribers assess your individual circumstances during a free online consultation lasting under three minutes. This clinical review ensures you receive the most appropriate treatment for your weight loss goals whilst maintaining full regulatory compliance with MHRA and GPhC standards.

Which Injection Offers the Best Value?

Value encompasses both clinical efficacy and cost-effectiveness over your treatment duration. Whilst Mounjaro demonstrates superior weight loss outcomes in trials, Wegovy offers an excellent balance of efficacy and affordability for most patients. Saxenda provides the lowest starting price, making it accessible for patients beginning their weight loss journey or those requiring daily dosing flexibility.

Many patients start with one treatment and transition to another based on their response, side effect profile, and budget. Our clinical team supports these transitions with appropriate dose titration and monitoring to optimise your outcomes throughout your weight loss programme.

Understanding Weight Loss Injection Pricing in the UK

Transparent pricing remains essential when comparing online pharmacies for weight loss injections. At Cured Pharmacy, we display upfront costs before your consultation begins—no hidden fees, no surprise charges at checkout. Our prices reflect the genuine cost of UK-licensed medications dispensed through our GPhC-registered pharmacy (9012511).

Pricing varies based on your prescribed dose, which increases gradually during the titration phase to minimise gastrointestinal side effects. For example, Mounjaro treatment typically begins at 2.5mg weekly, escalating to maintenance doses of 5mg, 10mg, or 15mg depending on your response and tolerability. Each dose increment represents a different price point, which your prescriber will discuss during your clinical assessment [1].

We guarantee the lowest prices in the UK for genuine licensed medications. Unlike some providers who advertise low entry prices but charge significantly more for therapeutic doses, our pricing structure remains competitive across all dose strengths. Every prescription includes free delivery with discreet packaging, ensuring complete privacy throughout your treatment journey.

Clinical Evidence Behind Weight Loss Injections

The efficacy of GLP-1 treatments is supported by extensive randomised controlled trials involving tens of thousands of participants. The STEP programme evaluated semaglutide across diverse patient populations, demonstrating consistent weight loss outcomes alongside improvements in cardiovascular risk markers, HbA1c levels, and quality of life measures [2].

The SURPASS trial series established tirzepatide as the most effective weight loss medication currently available, with SURPASS-2 showing superior outcomes compared to semaglutide 1mg in direct comparison. Participants receiving tirzepatide 15mg achieved average weight reductions of 12.4kg compared to 6.2kg with semaglutide over 40 weeks—a clinically meaningful difference [5].

Long-term data from the SELECT cardiovascular outcomes trial demonstrated that semaglutide reduced major adverse cardiovascular events by 20% in patients with established cardiovascular disease, supporting the broader health benefits beyond weight reduction alone [6]. These findings informed NICE guidance and NHS prescribing policies for GLP-1 treatments in weight management.

Real-World Effectiveness vs Clinical Trials

Whilst clinical trials occur under controlled conditions, real-world evidence confirms that patients achieve meaningful weight loss when GLP-1 injections are combined with lifestyle modifications. Adherence remains the strongest predictor of success—patients who maintain regular injections and attend follow-up consultations experience outcomes comparable to trial participants [4].

Our clinical team at Cured Pharmacy provides ongoing support throughout your treatment, with regular check-ins to monitor your progress, manage side effects, and adjust dosing as needed. This continuity of care optimises your likelihood of achieving and maintaining your weight loss goals.

Managing Side Effects of Weight Loss Injections

Gastrointestinal side effects represent the most common adverse reactions with GLP-1 treatments, affecting up to 44% of patients in clinical trials. Nausea, vomiting, diarrhoea, and constipation typically occur during dose escalation and diminish as your body adapts to the medication [1][2].

Starting at the lowest therapeutic dose and increasing gradually every four weeks significantly reduces the severity of these side effects. Eating smaller portions, avoiding high-fat meals, and staying well-hydrated can further minimise gastrointestinal discomfort. Most patients find these effects manageable and temporary, resolving within 4-8 weeks of reaching their maintenance dose [3].

Serious adverse events remain rare but require immediate medical attention. These include severe abdominal pain potentially indicating pancreatitis, persistent vomiting leading to dehydration, changes in vision, or signs of thyroid tumours such as a lump in the neck. Our clinical team provides comprehensive safety information during your consultation and remains available for any concerns throughout your treatment [4].

Getting Started with Cheap Weight Loss Injections UK

Beginning your weight loss journey with GLP-1 injections at Cured Pharmacy involves three straightforward steps. First, complete our free online consultation—a clinical questionnaire taking under three minutes that our UK prescribers review to assess your suitability. Second, if approved, select your preferred treatment and dose based on your prescriber's recommendation. Third, receive your medication via discreet next-day delivery with full injection instructions and ongoing clinical support.

All weight loss injections are prescription-only medications in the UK, meaning you cannot legally purchase them without clinical assessment by a registered prescriber. Our consultation process ensures compliance with MHRA regulations whilst providing convenient access to these transformative treatments from the comfort of your home.

We accept patients with a BMI of 30 or above, or 27 and above with weight-related health conditions such as type 2 diabetes, hypertension, or sleep apnoea. Your prescriber will verify your eligibility and discuss realistic expectations—most patients should aim for gradual weight loss of 0.5-1kg weekly alongside dietary modifications and increased physical activity [5][6].

What to Expect in Your First Month

During your initial four weeks on the starting dose, you may notice reduced appetite and earlier satiety when eating. Some patients experience mild nausea or fatigue as their body adjusts. Weight loss during this titration phase averages 2-4kg, with more substantial reductions occurring once you reach therapeutic maintenance doses [2].

Our clinical team monitors your progress and adjusts your treatment plan based on your individual response. This personalised approach ensures you receive optimal outcomes whilst minimising side effects throughout your weight loss journey with cheap weight loss injections UK from Cured Pharmacy.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
4. Medicines and Healthcare products Regulatory Agency. (2023). GLP-1 Receptor Agonists: Reports of Diabetic Ketoacidosis When Concomitant Insulin Was Rapidly Reduced or Discontinued. Drug Safety Update, 16(9), A1.
5. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
6. Lincoff, A. M., et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 389(24), 2221–2232. https://doi.org/10.1056/NEJMoa2307563

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and weight loss outcomes depend on adherence to treatment, lifestyle modifications, and individual patient factors.